vs
爱德华生命科学（EW）与普信集团（TROW）财务数据对比。点击上方公司名可切换其他公司
普信集团的季度营收约是爱德华生命科学的1.2倍（$1.9B vs $1.6B），爱德华生命科学净利率更高（23.1% vs 23.0%，领先0.1%），爱德华生命科学同比增速更快（16.7% vs 6.0%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs 5.1%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
普信集团（T. Rowe Price）是美国上市的全球性资产管理机构，面向个人、机构及金融中介提供基金、次咨询服务、独立账户管理、退休规划等多元金融服务。截至2023年，公司管理资产规模超1.51万亿美元，年营收64.8亿美元，位列美国财富1000强第537位。
EW vs TROW — 直观对比
营收规模更大
TROW
是对方的1.2倍
$1.6B
营收增速更快
EW
高出10.7%
6.0%
净利率更高
EW
高出0.1%
23.0%
两年增速更快
EW
近两年复合增速
5.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.9B |
| 净利润 | $380.7M | $445.3M |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | 24.4% |
| 净利率 | 23.1% | 23.0% |
| 营收同比 | 16.7% | 6.0% |
| 净利润同比 | 6.8% | 1.2% |
| 每股收益（稀释后） | $0.66 | $1.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWTROW
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.9B | ||
| Q3 25 | $1.6B | $1.9B | ||
| Q2 25 | $1.5B | $1.7B | ||
| Q1 25 | $1.4B | $1.8B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.4B | $1.8B | ||
| Q2 24 | $1.4B | $1.7B |
净利润EWTROW
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $445.3M | ||
| Q3 25 | $291.1M | $646.1M | ||
| Q2 25 | $333.2M | $505.2M | ||
| Q1 25 | $358.0M | $490.5M | ||
| Q4 24 | $385.6M | $439.9M | ||
| Q3 24 | $3.1B | $603.0M | ||
| Q2 24 | $366.3M | $483.4M |
毛利率EWTROW
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
营业利润率EWTROW
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | 24.4% | ||
| Q3 25 | 19.8% | 34.0% | ||
| Q2 25 | 26.8% | 27.8% | ||
| Q1 25 | 27.9% | 33.8% | ||
| Q4 24 | 22.6% | 31.2% | ||
| Q3 24 | 25.9% | 34.4% | ||
| Q2 24 | 26.8% | 32.6% |
净利率EWTROW
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | 23.0% | ||
| Q3 25 | 18.7% | 34.1% | ||
| Q2 25 | 21.7% | 29.3% | ||
| Q1 25 | 25.3% | 27.8% | ||
| Q4 24 | 27.8% | 24.1% | ||
| Q3 24 | 226.7% | 33.8% | ||
| Q2 24 | 26.7% | 27.9% |
每股收益（稀释后）EWTROW
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $1.98 | ||
| Q3 25 | $0.50 | $2.87 | ||
| Q2 25 | $0.56 | $2.24 | ||
| Q1 25 | $0.61 | $2.15 | ||
| Q4 24 | $0.65 | $1.91 | ||
| Q3 24 | $5.13 | $2.64 | ||
| Q2 24 | $0.61 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $3.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $10.9B |
| 总资产 | — | $14.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWTROW
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $3.4B | ||
| Q3 25 | $3.8B | $3.6B | ||
| Q2 25 | $4.1B | $3.1B | ||
| Q1 25 | $3.9B | $2.8B | ||
| Q4 24 | $4.0B | $2.6B | ||
| Q3 24 | $4.4B | $3.2B | ||
| Q2 24 | $2.0B | $2.7B |
股东权益EWTROW
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $10.9B | ||
| Q3 25 | $10.2B | $10.8B | ||
| Q2 25 | $10.5B | $10.6B | ||
| Q1 25 | $10.1B | $10.4B | ||
| Q4 24 | $10.0B | $10.3B | ||
| Q3 24 | $9.5B | $10.2B | ||
| Q2 24 | $7.4B | $9.9B |
总资产EWTROW
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $14.3B | ||
| Q3 25 | $13.3B | $14.7B | ||
| Q2 25 | $13.5B | $14.3B | ||
| Q1 25 | $13.0B | $14.0B | ||
| Q4 24 | $13.1B | $13.5B | ||
| Q3 24 | $13.0B | $13.7B | ||
| Q2 24 | $10.1B | $13.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-18.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-85.4M |
| 自由现金流率自由现金流/营收 | — | -4.4% |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | — | -0.04× |
| 过去12个月自由现金流最近4个季度 | — | $1.5B |
8季度趋势，按日历期对齐
经营现金流EWTROW
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $-18.7M | ||
| Q3 25 | $573.7M | $609.3M | ||
| Q2 25 | $290.2M | $529.9M | ||
| Q1 25 | $280.4M | $632.9M | ||
| Q4 24 | $-127.5M | $-281.9M | ||
| Q3 24 | $351.8M | $652.5M | ||
| Q2 24 | $371.5M | $677.7M |
自由现金流EWTROW
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $-85.4M | ||
| Q3 25 | $516.2M | $546.0M | ||
| Q2 25 | $240.9M | $467.7M | ||
| Q1 25 | $224.4M | $550.9M | ||
| Q4 24 | $-177.3M | $-394.9M | ||
| Q3 24 | $299.9M | $547.9M | ||
| Q2 24 | $286.1M | $574.4M |
自由现金流率EWTROW
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | -4.4% | ||
| Q3 25 | 33.2% | 28.8% | ||
| Q2 25 | 15.7% | 27.1% | ||
| Q1 25 | 15.9% | 31.2% | ||
| Q4 24 | -12.8% | -21.6% | ||
| Q3 24 | 22.1% | 30.7% | ||
| Q2 24 | 20.9% | 33.1% |
资本支出强度EWTROW
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 3.4% | ||
| Q3 25 | 3.7% | 3.3% | ||
| Q2 25 | 3.2% | 3.6% | ||
| Q1 25 | 4.0% | 4.6% | ||
| Q4 24 | 3.6% | 6.2% | ||
| Q3 24 | 3.8% | 5.9% | ||
| Q2 24 | 6.2% | 6.0% |
现金转化率EWTROW
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | -0.04× | ||
| Q3 25 | 1.97× | 0.94× | ||
| Q2 25 | 0.87× | 1.05× | ||
| Q1 25 | 0.78× | 1.29× | ||
| Q4 24 | -0.33× | -0.64× | ||
| Q3 24 | 0.11× | 1.08× | ||
| Q2 24 | 1.01× | 1.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
TROW
| Asset Management1 | $1.7B | 90% |
| Administrative Distribution Servicing And Other Fee Revenue | $141.5M | 7% |
| Other | $40.8M | 2% |
| Performance Based Advisory Fees | $14.2M | 1% |
